Robuta

Background/Objectives: Tissue niches, such as those in the spleen, bone marrow, and lymph nodes, are crucial for the survival and growth of leukemic cells in...

A general framework captures the evolutionary routes leading to the formation and progression of tumors.

The American Journal of Managed Care provides insights into the latest news and research in managed care across multimedia platforms.

BGB324 has potential application as a novel treatment for Chronic Myeloid Leukemia (CML), was presented in a poster at the Annual Meeting of the American...

This is the first large-scale cross-country analysis of patients with chronic lymphocytic leukemia (CLL) aimed to evaluate the incidence, types, and key...

Maintenance therapy helps some patients with chronic leukemia lower their risk of a recurrence, but sticking to a prescription can be hard. Elias Jabbour,...

TCL1 transgenic mice as a model for CD49d-high chronic lymphocytic leukemia

Researchers leading the SWOG S1712 clinical trial have found that adding ruxolitinib to standard tyrosine kinase inhibitor (TKI) treatment for patients with...

Cerebral aspergillosis commonly affects immunocompromised hosts, primarily patients on immunosuppressive therapy and those with acquired or immunodeficient...

Chronic Lymphocytic Leukemia slowly takes the life of anyone who has it. Unless of course, they do not know they have it like my mom, until the latter year. I...

Targeted therapy uses drugs to target specific molecules on the surface of cancer cells. Learn when it is used to treat chronic myeloid leukemia (CML).

Apr 15, 2021 - Chronic myeloid leukemia (CML) is a type of blood cancer that has three phases. Learn about its symptoms, treatments, diagnosis, and more.

Understand the causes, symptoms, and risk factors of chronic lymphocytic leukemia.

May 27, 2021 - Agent Orange is an herbicide that is carcinogenic to humans. This means that it can cause cancer, including chronic lymphocytic leukemia. Learn more.

Feb 9, 2021